Dexlansoprazole
Product Images NDC 24979-704
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 24979-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Twi Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Dexlansoprazole 02)
This is a graph that shows the plasma concentration (in ng/mL) of DEXLANSOPRAZOLE at two different dosages (30mg and 60mg) over a period of 20 hours. The concentration levels for each dosage start at approximately 1200 ng/mL and gradually decrease over time. The graph also includes a time scale on the x-axis, indicating the elapsed time in hours from the start of the study.*
Principal Display Panel (30 mg Capsule Bottle Label)
Principal Display Panel (60 mg Capsule Bottle Label)
This is a medication for which the usual dosage can be found in the package insert. The medication is Dexlansoprazole and each blue capsule features delayed-release 60 mg of the medication. It is important to ensure that the seal of the bottle is intact. The medication should be stored between 20 and 25°C (68 to 77°F), with excursions permitted to 30°C (59 to 86°F). It is only available with a prescription and has been manufactured for TWi Pharmaceuticals USA. The GTIN code for the medication is 00324979704067, and a pack consists of 30 capsules.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.